Strategic Acquisition of The Healthy Chef & Capital Raise
Released
Released
Announcement PDF
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
ASX ANNOUNCEMENT
Strategic Acquisition of The Healthy Chef
& Capital Raise
HIGHLIGHTS
•
Elixinol Wellness Ltd has signed a binding Business Sale Agreement to acquire The Healthy Chef,
a premium lifestyle brand offering clean nutrition for women’s health, inner beauty, and wellbeing.
•
The acquisition adds a comprehensive branded business that is expected to enhance revenue,
margins, and EBITDA. It complements Elixinol’s current business and brand portfolio, providing
synergies for scaling and cost optimisation in both Australia and the USA.
•
The acquisition advances Elixinol’s path to positive cash flow and EBITDA expansion, supported
by diversified revenue streams aligned with the Company’s core principles of sustainable
nutrition.
•
Elixinol Wellness has received commitments for approximately A$1.1 million through an
institutional Placement which received strong support from new and existing institutional and
sophisticated investors.
•
The SPP offers existing eligible shareholders the opportunity to participate on the same terms as
Placement participants to raise up to an additional A$0.5 million.
•
Proceeds from the Placement and SPP will fund the Acquisition and provide additional working
capital to drive growth .
3 October 2024, Melbourne: Elixinol Wellness Ltd (ASX: EXL) ("EXL," "Elixinol," or "the Company")
is pleased to announce that is has entered into a binding Business Sale Agreement ("Business Sale
Agreement") to acquire 100% of the assets ("Acquisition") of The Healthy Chef Pty Ltd, Healthy Chef
Stock & Research Development, and EHealth And Wellbeing Pty Ltd ("Healthy Chef ," or "Healthy
Chef Trading Entities").
The Company has secured commitments for a capital raise through a A$1.1 million institutional
Placement of up to approximately 244 million new fully paid ordinary shares in EXL ("Placement"),
and is launching a non-underwritten Share Purchase Plan ("SPP") of up to a maximum of A$0.5
million by the issue of up to approximately 111 million new fully paid ordinary shares in EXL ("Capital
Raising"). These funds will be used to complete the Acquisition and support EXL with additional
marketing investment and working capital to drive near term growth initiatives.
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Healthy Chef Acquisition
The Healthy Chef was founded in Australia in 2006 by Teresa Cutter, a nutritionist, wellness coach
and celebrity chef. The brand reflects, her belief that wholefood nutrition is essential for optimal
health, fitness, and wellbeing.
Healthy Chef is a premium lifestyle brand providing clean nutrition for women’s health, inner beauty,
and wellbeing. Its comprehensive portfolio of 28 products targets high-demand segments, including
weight loss, health and fitness, stress, sleep, menopause, and immunity. Over the past 18 years,
Healthy Chef has developed a loyal customer base in Australia and built a rich library of product
innovation, digital content, and intellectual property.
Elixinol is acquiring The Healthy Chef business, including its assets (such as intellectual property)
and stock as a going concern.
David Fenlon, EXL’s Non-executive Chair, commented:
“We are thrilled to announce the acquisition of The Healthy Chef, which represents a strategic
catalyst for our growth ambitions. This acquisition is expected to be margin accretive with
synergies and cost savings projected to significantly improve Group gross margins. Additionally,
it offers substantial growth potential in untapped consumer segments. We are delighted to
welcome Teresa Cutter as a global brand ambassador, and look forward to working closely with
her to unlock the full potential of The Healthy Chef brand.”
Further information about The Healthy Chef is contained at the end of this ASX Announcement and
in the supplementary Investor Presentation.
Acquisition Rationale
EXL is building a profitable ‘House of Brands’ in clean nutrition, achieving record revenues, strong
growth, and category leadership in Australia, with the USA identified as the next growth horizon.
The Acquisition provides EXL with a cornerstone branded business that is:
•
•
•
•
•
•
Highly complementary to the existing brand portfolio;
Immediate revenue growth, cost synergies, and positive EBITDA contribution;
A 62% gross margin in FY24, forecast to increase blended Group margins;
Expanded scale to optimise returns and reduce risk;
Leverage of the existing team, infrastructure, and distribution channels; and
Strong appeal in the U.S. wellness market with IP protection and a licencing agreement.
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Business Sale Agreement
The transaction is structured so that, in addition to the initial cash consideration, a substantial
portion of the deferred payments will be based on gross profits generated by The Healthy Chef
business, alongside the synergistic benefits from existing EXL operations.
The total consideration ("Purchase Price") under the Business Sale Agreement will range between
A$3.1 million and A$5.5 million, with the final amount determined on 1 March 2028 ("Final
Settlement"). The Purchase Price will be calculated on a sliding scale, with a minimum of $3.1
million and a maximum of $5.5 million if Healthy Chef generates over $10.0 million in gross revenue
in FY27.
Payment of Consideration:
100 million fully paid ordinary shares in EXL to the value of A$400,000 ("Consideration Shares"),
calculated at a 30-day VWAP on 10 September 2024 of $0.004, subject to shareholder approval and
under 12 months escrow period.
Deferred Consideration Payment
The first two Deferred Consideration Amounts (outlined below) will be paid to the Healthy Chef (HC)
Trust on the Deferred Consideration Payment Dates in the following proportions:
a) A$600,000 in cash ("Initial Cash Consideration") at closing of the transaction ("Completion");
b) A$450,000 in cash on the 1st annual anniversary of Completion ("First Deferral Payment");
c) A$600,000 in cash on the 2nd annual anniversary of Completion ("Second Deferral Payment");
d) Remainder of the Purchase Price in cash on Final Settlement date ("Final Deferred Payment").
The third and final Deferred Payment (Final Deferred Payment) will be calculated on 1 March 2028
(Calculation Date) and paid to the HC Trust in cash within 10 Business Days of the Calculation Date
in accordance with the following scale:
If Revenue for the period from 1 January 2027 to 31 December 2027 (FY27) is less than $3,500,000,
the Final Deferred Payment will be $1,050,000, meaning the Total Purchase Price is $3,100,000.
If FY27 Revenue exceeds $3,500,000 but is less than $6,000,000, the Final Deferred Payment will be
$1,050,000 plus 50% of the incremental Revenue over $3,500,000, meaning a Total Purchase Price
of between $3,100,001 and $4,350,000.
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
If FY27 Revenue exceeds $6,000,000, the Final Deferred Payment will be $2,300,000 plus 25% of
Revenue over $6,000,000 up to the maximum Purchase Price of $5,900,000, meaning a Total
Purchase Price of between $4,350,001 and $5,500,000
Under the Business Sale Agreement, EXL Shareholders must approve the issue of the Consideration
Shares. In the event EXL is unable to secure the requisite shareholder approval to issue the
Consideration Shares in accordance with ASX Listing 7.1, ., EXL will pay The Healthy Chef the cash
equivalent of the Consideration Shares (A$400,000). The Consideration Shares will be subject to a
voluntary 12-month escrow period.
At Completion, Elixinol will engage Healthy Chef’s founder, Teresa Cutter, as a consultant for three
years, with an option to extend for another three years, providing services such as global brand
ambassadorship, and product and recipe development.
A summary of the material terms of the Business Sale Agreement is appended to this ASX
Announcement at Schedule 1.
Capital Raising
Placement
EXL has secured commitments for an institutional Placement to raise A$1.1 million through the issue
of approximately 244 million new fully paid ordinary shares ("New Shares"). The New Shares under
the Placement are being issued under the Company’s available placement capacity under ASX
Listing Rules 7.1 and 7.1A.
The single-tranche Placement priced at A$0.0045 per New Share ("Placement Price"), was not
underwritten and represents a 10.0% discount to the last close and 6.9% 10-day VWAP.
For every three (3) New Shares subscribed for in the Placement, participants will receive one (1) free
attaching listed option, issued under the same existing ASX-listed option EXLO ("Attaching Option").
The Attaching Options have an exercise price of A$0.0075 and expire on 22 March 2027. The
Attaching Options under the Placement are being issued under the Company's available placement
capacity under ASX Listing Rule 7.1.
Canaccord Genuity (Australia) Limited is the lead manager for the Capital Raising.
Share Purchase Plan (SPP)
The Company is offering eligible shareholders in Australia and New Zealand (as at the record date of
7.00pm on 2 October 2024) the opportunity to subscribe for approximately 111 million New Shares
under a non-underwritten SPP, capped at A$0.5 million.
The SPP will be offered at an issue price of A$0.0045 per New Share. For every three (3) New
Shares subscribed for in the SPP, participants will receive one (1) free attaching listed option, to
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
be issued under the same existing ASX listed option EXLO. The Attaching Options have an exercise
price of A$0.0075 expiring on 22 March 2027.
Shareholder approval under ASX Listing Rule 7.1 is required for the issue of securities under the
SPP. Allotment under the SPP (subject to shareholder approval) will occur after shareholder
approval has been obtained. The notice of the general meeting at which shareholder approval will be
sought will be lodged with the ASX and despatched to shareholders as soon as reasonably
practicable.
The New Shares and Attaching Options under the SPP will be offered pursuant to a prospectus issued
in accordance Section 713 of the Corporations Act ("Prospectus"). Placement subscribers will also
be eligible to apply for their Attaching Options under the Prospectus.
Further details regarding the SPP will be made available to eligible shareholders in the Prospectus to
be lodged with ASIC and ASX on or around 7 October 2024, despatch (in hard copy or by electronic
link) expected around 10 October 2024.
New shares issued under both the Placement and SPP will be fully paid and rank equally in all
respects with existing shares from the date of the allotment.
Indicative Key Dates*
Record Date
Wednesday 2 October 2024 (7 pm)
SPP and Placement Announcement
Thursday 3 October 2024
Company resumes trading
Friday 4 October 2024
Lodgement of Prospectus with ASX and ASIC
Monday 7 October 2024
Despatch of Prospectus and SPP Offer opens
Thursday 10 October 2024
Closing of SPP Offer
Friday 25 October 2024 (5 pm)
Allotment and issue of New Shares under SPP Offer
Thursday 21 November 2024
*Dates/times are indicative and subject to change. All times / dates are in reference to Sydney time .
Authorised for release by the Board of Directors of Elixinol Wellness Limited.
For further information, please contact:
David Fenlon, Non-executive Chair
David.fenlon@elixinolwellness.com
Pauline Gately, Non-executive Director
Pauline.gately@elixinolwellness.com
For more information visit Elixinol Wellness Investor Hub: https://investorhub.elixinolwellness.com
About Elixinol Wellness
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Elixinol Wellness Limited (ASX: EXL) is a leader in the global hemp industry, innovating, marketing, and selling
hemp and other plant-derived food, skincare, and nutraceutical products.
In Australia, Elixinol Wellness operates a vertically integrated business which produces, manufactures, and
distributes a range of highly complementary products delivered across four verticals – human nutrition, human
wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp
Foods Australia, Mt Elephant, Ananda Food, Soul Seed, and Field Day and are sold through grocery, wholesale,
and e-commerce channels. The Australian Superfood Co also supplies Australian natives and superfood
ingredients to white label customers as well as food, beverage, and beauty manufacturers.
Elixinol USA sells high quality Elixinol branded hemp and other plant-derived nutraceutical and skincare
products. www.elixinolwellness.com
About The Healthy Chef
The Healthy Chef is a premium producer of wellness and health products under the brand Healthy Chef ® with
a loyal customer base in Australia and significant library of product innovation, content and intellectual
property generated over 18 years.
Healthy Chef® was founded in 2006 by Teresa Cutter, a nutritionist, wellness coach and chef, who believes
wholefood nutrition is essential for optimal health, fitness, and wellbeing. The brand has over a decade of
earned brand goodwill with trusted reputation for quality products, meaningful engagement with the
community, strong social currency, and media exposure.
The Healthy Chef® premium range of functional food products are proudly made in Australia from the purest
wholefood ingredients with science-based formulations to deliver maximum health impact, and are free from
gluten, fillers, gums and sugar without compromising on taste. Healthy Chef® also inspires women to
incorporate healthy eating into their everyday lives with a comprehensive collection of cookbooks, meal
planning mobile application, blog and extensive social media of rich dynamic content to create a deeper
connection with consumers and deliver a powerful brand experience through its direct-to-consumer
eCommerce platform and App.
The Healthy Chef® brand has a diverse offering with seamless omnichannel brand touchpoints to connect with
women on their personalised health and wellness journey, including:
–
–
–
Nutritional Products - 28 products based on protein, collagen, probiotics, and supplements to provide
benefits for weight loss, gut health, stress, sleep, menopause, and immunity.
App - subscription based meal planning App with thousands of interactive healthy recipes.
Cookbook series - 7 cookbooks involving hundreds of hours of creativity in the kitchen and studio
production.https://thehealthychef.com/
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Disclaimer
Forward looking statements
This document contains certain "forward-looking statements". The words "expect", "anticipate", "estimate",
"intend", "believe", "guidance", "should", "could", "may", "will", "predict", "plan" and other similar expressions
are intended to identify forward-looking statements. Indications of, and guidance on, future earnings and
financial position and performance are also forward-looking statements. Forward-looking statements,
opinions and estimates provided in this document are based on assumptions and contingencies that are
subject to change without notice and involve known and unknown risks and uncertainties and other factors
that are beyond the control of EXL, its directors and management. This includes statements about market and
industry trends, which are based on interpretations of current market conditions.
Forward-looking statements are provided as a general guide only and should not be relied upon as an indication
or guarantee of future performance. Actual results, performance or achievements may differ materially from
those expressed or implied in such statements and any projections and assumptions on which these
statements are based. These statements may assume the success of EXL’s business strategies. The success
of any of those strategies will be realised in the period for which the forward-looking statement may have been
prepared or otherwise. Readers are cautioned not to place undue reliance on forward-looking statements and
except as required by law or regulation, none of EXL, its representatives or advisers assumes any obligation to
update these forward-looking statements. No representation or warranty, express or implied, is made as to the
accuracy, likelihood of achievement or reasonableness of any forecasts, prospects, returns or statements in
relation to future matters contained in this document. The forward-looking statements are based on
information available to EXL as at the date of this document. Except as required by law or regulation (including
the ASX Listing Rules), none of EXL, its representatives or advisers undertakes any obligation to provide any
additional or updated information whether as a result of a change in expectations or assumptions, new
information, future events, or results or otherwise. Indications of, and guidance or outlook on, future earnings
or financial position or performance are also forward-looking statements.
Not an offer in the United States
This document has been prepared for publication in Australia and may not be released to US wire services or
distributed in the United States. This document does not constitute an offer to sell, or a solicitation of an offer
to buy, securities in the United States or in any other jurisdiction in which such an offer would be illegal. Any
securities described in this document have not been, and will not be, registered under the U.S. Securities Act
of 1933, as amended (the “US Securities Act”) or the securities laws of any state or jurisdiction of the United
States. Accordingly, the securities described in this document may not be offered or sold, directly or indirectly,
in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the US Securities Act and applicable securities laws of any state or other jurisdiction of the
United States
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Schedule 1 – Key Terms of the Business Sale Agreement
Item
Detail
Healthy Chef
Trading Entities
The Healthy Chef Trading Entities comprises of:
(a) The Healthy Chef Pty Ltd ACN 119 224 654 as trustee for the Healthy Chef
Trust;
(b) Healthy Chef Stock & Research Development Pty Ltd ACN 105 682 782; and
(c) EHealth And Wellbeing Pty Ltd ACN 627 206 491.
Consideration
•
Initial Cash Consideration: A$600,000 payable at Completion;
•
Consideration Shares: Fully paid ordinary shares in the Buyer with an aggregate value
of $400,000 calculated based on the 30-day VWAP on 10 September 2024.
•
Deferred Consideration Payment: The first two of three Deferred Consideration
Amounts will be paid to the HC Trust on the Deferred Consideration Payment Dates in
the following proportions:
– A$450,000 in cash on the 1st annual anniversary of Completion (First Deferral
Payment)
– $600,000 in cash on the 2nd annual anniversary of Completion (Second Deferred
Payment)
•
The third and final Deferred Consideration Payment (Final Deferred Payment) to be
calculated on 1 March 2028 (Calculation Date) and paid to the HC Trust in cash
within 10 Business Days of the Calculation Date according to the following scale:
– If the Revenue for the period from 1 January 2027 to 31 December 2027 (FY27
Revenue Period) is less than $3,500,000 (FY27 Revenue), the Final Deferred
Payment will be $1,050,000 to meet the minimum threshold, meaning the Total
Purchase Price is $3,100,000.
– If FY27 Revenue exceeds $3,500,000 but is less than $6,000,000, the Final
Deferred Payment will be $1,050,000 plus 50% of the incremental Revenue over
$3,500,000, meaning the Total Purchase Price is between $3,100,001 $4,350,000).
– If FY27 Revenue exceeds $6,000,000, the Final Deferred Payment will be
$2,300,000 plus 25% of Revenue over $6,000,000 up to the maximum Purchase
Price of $5,900,000 (Total Purchase Price = $4,350,001 -$5,500,000).
Escrow
Arrangement
Consideration Shares to be held in voluntary escrow for 12months following issue.
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Conditions
Completion under the Business Purchase Agreement is subject to a set of customary
conditions.
Key Assets
All of the assets necessary to carry on the Business including the Cutter Family Trust
Assets, the Healthy Chef IP, the HC Trust Assets, the HC Stock & Research Assets and the
Ehealth & Wellbeing Assets, including:
•
the Business Name;
•
the IP Licences;
•
the Business Records;
•
the Contracts;
•
the Goodwill; and
•
the Promotional Material.
Level 4, 100 Albert Road, South Melbourne VIC 3205
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Share your feedback
Discover